PSYCH SYMPOSIUM 2026
TBA
•
TBA
•
TBA
•
TBA • TBA • TBA •
Previous Speakers
-
![David Nutt headshot]()
Prof David Nutt
Founder
Drug Science
-
![Anne Schlag headshot]()
Dr Anne Katrin Schlag
Head of Research
Drug Science
-
![David Erritzoe]()
Dr David Erritzoe
Clinical Director
Centre for Psychedelic Research at Imperial College London
-
![Keith Abraham headshot]()
Keith Abraham
Founder
Heroic Hearts UK
-
![Nige Netzband headshot]()
Nige Netzband
Founder
Athletes Journey Home UK
-
![Hannah Thurgur Headshot]()
Dr Hannah Thurgur
Clinical Trial Manager
Imperial College London
-
![Dr Rayyan Zafar Headshot]()
Dr Rayyan Zafar
Neuropsychopharmacologist and Postdoctoral Fellow
Imperial College London
About psych symposium
PSYCH Symposium, a collaboration between PSYCH and Drug Science, is a one-day psychedelic conference in London bringing together European psychedelic leaders to explore what’s next for the industry.
CONWAY HALL, DECEMBER 4
X
EVENT Partnership
Partnering with PSYCH enables organisations to engage an audience ready to support the development of psychedelic healthcare, such as researchers, regulators and investors.
WHY LONDON?
The UK is home to world-leading psychedelic research institutions and publicly traded companies, with direct access to London’s capital markets. This lays the foundations for a flourishing domestic industry, with the PSYCH Symposium championing the emerging ecosystem.
Our PURPOSE
Against the backdrop of a deepening mental health crisis, psychedelic medicines have demonstrated safety and efficacy in clinical trials.
To promote their groundbreaking potential, experts from the life sciences industry present their research at PSYCH Symposium: London.